Evidence map›Paper›PMID 26437021›Full record

ArticleAmerican journal of respiratory cell and molecular biology2016

Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.

Yohannes A Mebratu, Jennifer Tipper, Hitendra S Chand, Stephanie Walton, Kevin S Harrod, Yohannes Tesfaigzi

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Anellovirus-mediated interferon dysregulation enhances virus-induced lung injury.American journal of respiratory cell and molecular biology · 2026
    Article
  2. BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yohannes A Mebratu1 Chronic Obstructive Pulmonary Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Jennifer Tipper2 Department of Anesthesiology and Perioperative Medicine, School of Medicine, University of Alabama Birmingham, Birmingham, Alabama.
Hitendra S Chand1 Chronic Obstructive Pulmonary Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Stephanie Walton1 Chronic Obstructive Pulmonary Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Kevin S Harrod2 Department of Anesthesiology and Perioperative Medicine, School of Medicine, University of Alabama Birmingham, Birmingham, Alabama.
Yohannes Tesfaigzi1 Chronic Obstructive Pulmonary Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Lovelace Respiratory Research Institute · USUniversity of Alabama at Birmingham · US

Funding

Targeting MMP9 to Improve Outcomes in Serious Influenza InfectionsR01AI111475 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S, LEVY, BRUCE D · 2014 to 2018
$4.3M
Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus InfectionR21AI115291 · NIAID · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI MEBRATU, YOHANNES AFEWORK · 2015 to 2016
$600k
NIAID NIH HHS R01 AI111475NIAID NIH HHS R21 AI115291
6 · The paper itself

Abstract

Influenza virus induces apoptosis in infected cells to promote viral replication by manipulating the host cell death signaling pathway. Although some Bcl-2 family proteins play a role in the replication of influenza A virus (IAV), the role of cell death pathways in the viral replication cycle is unclear. We investigated whether deficiency of the proapoptotic Bcl-2 family protein, Bik, plays a role in IAV replication. IAV replication was attenuated in mouse airway epithelial cells (MAECs) from bik(-/-) compared with bik(+/+) mice, as indicated by reduced viral titers. Bik(-/-) MAECs showed more stable transepithelial resistance after infection than did bik(+/+) MAECs, were less sensitive to infection-induced cell death, and released fewer copies of viral RNA. Similar results were obtained when Bik expression was suppressed in human airway epithelial cells (HAECs). Bik(+/+) mice lost weight drastically and died within 8 days of infection, whereas 75% of bik(-/-) mice survived infection for 14 days and were 10-fold less likely to die from infection compared with bik(+/+) mice. IAV infection activated caspase 3 in bik(+/+) but not in bik(-/-) MAECs. Cleavage of viral nucleoprotein and M2 proteins were inhibited in bik(-/-) MAECs and when caspase activation was inhibited in HAECs. Furthermore, Bik deficiency impaired cytoplasmic export of viral ribonucleoprotein. These studies suggest a link between Bik-mediated caspase activation and cleavage of viral proteins. Thus, inhibition of proapoptotic host factors such as Bik and downstream mediators of cell death may represent a novel approach to influenza treatment.

Indexed as

Adaptor Proteins, Signal TransducingAlveolar Epithelial CellsAnimalsApoptosis Regulatory ProteinsCaspase 3Cell DeathChick EmbryoCytoplasmDogsEnzyme ActivationHumansInfluenza A virusInfluenza, HumanMadin Darby Canine Kidney CellsMembrane ProteinsMice, Inbred C57BLAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBIK protein, humanBik protein, mouseCaspase 3Membrane ProteinsMitochondrial ProteinsRibonucleoproteinsViral ProteinsBcl-2 family proteinBikcaspaseinfluenza A virus infectionmice

Identifiers

PMID26437021
PMCPMC4942193
OpenAlexW1827963371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.